I. Dicembrini

发表

Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials

G. Sesti, F. Andreozzi, M. Monami, 2017, Acta Diabetologica.

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis

N. Marchionni, M. Monami, I. Dicembrini, 2012, Experimental diabetes research.

Dipeptidyl peptidase‐4 inhibitors and pancreatitis risk: a meta‐analysis of randomized clinical trials

M. Monami, I. Dicembrini, E. Mannucci, 2014, Diabetes, obesity & metabolism.

Effects of antihypertensive treatments on incidence of diabetes: A case-control study

N. Marchionni, A. Ungar, M. Monami, 2012, Journal of Endocrinological Investigation.

Barriers and Potential Solutions to Providing Optimal Guideline-Driven Care to Patients With Diabetes in the U.S. Diabetes Care 2013;36:3843–3849

R. Vigersky, M. Monami, I. Dicembrini, 2013, Diabetes Care.

Drugs for type 2 diabetes: role in the regulation of bone metabolism.

I. Dicembrini, E. Mannucci, 2015, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

Pancreatitis and pancreatic cancer in patientes treated with dipeptidyl peptidase-4 inhibitors: an extensive and updated meta-analysis of randomized controlled trials.

M. Monami, I. Dicembrini, B. Nreu, 2019, Diabetes research and clinical practice.

A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients.

I. Dicembrini, E. Mannucci, C. Rotella, 2007, Diabetes research and clinical practice.

Brief report A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients

I. Dicembrini, E. Mannucci, C. Rotella, 2007 .

Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials.

G. Sesti, M. Monami, I. Dicembrini, 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Orlistat and sibutramine beyond weight loss.

I. Dicembrini, E. Mannucci, C. Rotella, 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Dypeptidylpeptidase-4 inhibitors and the cardiovascular system: How to manage the fil rouge.

M. Monami, I. Dicembrini, E. Mannucci, 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Nephrolitiasis and Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A Meta-analysis Of Randomized Controlled Trials.

M. Monami, I. Dicembrini, B. Nreu, 2019, Diabetes research and clinical practice.

Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials.

M. Monami, I. Dicembrini, B. Nreu, 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials

M. Monami, I. Dicembrini, E. Mannucci, 2016, Acta Diabetologica.

Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance

I. Dicembrini, C. Rotella, S. Giannini, 2013, Acta Diabetologica.

Hypertriglyceridaemic waist phenotype and β‐cell function in subjects with normal and impaired glucose tolerance

I. Dicembrini, C. Rotella, C. Rotella, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Inflammation Markers and Metabolic Characteristics of Subjects With 1-h Plasma Glucose Levels

I. Dicembrini, C. Rotella, B. Cresci, 2009, Diabetes Care.

Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network metanalysis of randomized, active comparator-controlled trials.

M. Monami, I. Dicembrini, E. Mannucci, 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study

V. Ricca, M. Monami, I. Dicembrini, 2012, Acta Diabetologica.

Low-carbohydrate diets and type 2 diabetes treatment: a meta-analysis of randomized controlled trials

M. Monami, I. Dicembrini, E. Mannucci, 2020, Acta Diabetologica.

Validation of a New Test for Assessing the Quality of Life Perceived in Patients with Type 1 Diabetes

I. Dicembrini, E. Mannucci, L. Pala, 2021 .

National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze‐Bagno A Ripoli study

M. Monami, I. Dicembrini, E. Mannucci, 2008, Diabetes, obesity & metabolism.

Incretin-based therapies and cardiovascular risk

I. Dicembrini, E. Mannucci, 2012, Current medical research and opinion.

Bone: Incretin Hormones Perceiver or Receiver?

I. Dicembrini, E. Mannucci, C. Rotella, 2012, Experimental diabetes research.

Deprescription in Elderly Patients with Type 2 Diabetes Mellitus.

M. Monami, I. Dicembrini, E. Mannucci, 2020, Diabetes research and clinical practice.

Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

N. Marchionni, A. Ungar, P. Bagnoli, 2013, Current medical research and opinion.

Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures

M. Monami, I. Dicembrini, E. Mannucci, 2011, Diabetes Care.

Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk: a meta‐analysis of randomized clinical trials

M. Monami, I. Dicembrini, E. Mannucci, 2014, Diabetes, obesity & metabolism.

Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials.

M. Monami, I. Dicembrini, E. Mannucci, 2014, Diabetes research and clinical practice.

Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials.

M. Monami, I. Dicembrini, E. Mannucci, 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels

I. Dicembrini, C. Rotella, B. Cresci, 2009 .

Brief review Incretin-based therapies and cardiovascular risk

I. Dicembrini, E. Mannucci, 2012 .

Cholelithiasis in patientes treated with glucagon-like peptide-1 receptor: an updated meta-analysis of randomized controlled trials.

M. Monami, I. Dicembrini, B. Nreu, 2020, Diabetes research and clinical practice.

Relationship between GLP‐1 levels and dipeptidyl peptidase‐4 activity in different glucose tolerance conditions

I. Dicembrini, E. Mannucci, C. Rotella, 2010, Diabetic medicine : a journal of the British Diabetic Association.

Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials

M. Monami, I. Dicembrini, E. Mannucci, 2011, Current medical research and opinion.

Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes.

I. Dicembrini, E. Mannucci, C. Rotella, 2004, Diabetes, nutrition & metabolism.

Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies

M. Monami, I. Dicembrini, E. Mannucci, 2021, Acta Diabetologica.

Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes

J. Chiorini, J. Egan, R. Vettor, 2012, PloS one.

Combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial

M. Caliri, M. Monami, I. Dicembrini, 2020, Diabetes, obesity & metabolism.

Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials

M. Monami, I. Dicembrini, B. Nreu, 2020, Acta Diabetologica.

Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients

N. Marchionni, M. Monami, I. Dicembrini, 2010 .

Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis Of Randomized Controlled Trials.

G. Sesti, M. Monami, I. Dicembrini, 2020, Diabetes research and clinical practice.

Effect of Dipeptidyl-Peptidase 4 Inhibitors on Circulating Oxidative Stress Biomarkers in Patients with Type 2 Diabetes Mellitus

L. Giovannelli, M. Lodovici, I. Dicembrini, 2020, Antioxidants.

Risk of myocardial infarction in trials with Dipeptidyl Peptidase-4 inhibitors: Is duration of study a real issue?

I. Dicembrini, E. Mannucci, 2015, International journal of cardiology.

Original article Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials

M. Monami, I. Dicembrini, E. Mannucci, 2011 .

Association Between Oral Isotretinoin Therapy and Unmasked Latent Immuno-Mediated Diabetes

I. Dicembrini, C. Rotella, G. Bardini, 2009, Diabetes Care.

3‐Iodothyronamine: a modulator of the hypothalamus‐pancreas‐thyroid axes in mice

G. Chiellini, A. Saba, M. Lodovici, 2012, British journal of pharmacology.

Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials

M. Monami, I. Dicembrini, E. Mannucci, 2013, Diabetes, obesity & metabolism.

Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study

M. Monami, I. Dicembrini, E. Mannucci, 2018, Journal of Endocrinological Investigation.

Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells

S. Gelmini, I. Dicembrini, E. Mannucci, 2012, Acta Diabetologica.

Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A Meta-analysis Of Randomized Controlled Trials.

M. Monami, I. Dicembrini, B. Nreu, 2019, Diabetes research and clinical practice.

Cigarette Smoking as a Predictor of Sodium–Glucose Cotransporter 2 Inhibitor–Associated Genital Infections: A Retrospective Cohort Study

I. Dicembrini, E. Mannucci, Daniele Scoccimarro, 2021, Diabetes Care.

Plasma Adiponectin and Hyperglycaemia in Diabetic Patients

Marco Brogi, Gianni Messeri, I. Dicembrini, 2003, Clinical chemistry and laboratory medicine.

Measurement of body composition as a surrogate evaluation of energy balance in obese patients.

I. Dicembrini, C. Rotella, 2015, World journal of methodology.

Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism.

M. Monami, I. Dicembrini, E. Mannucci, 2012, Journal of clinical lipidology.

Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists

I. Dicembrini, E. Mannucci, A. Ceriello, 2015, Diabetes Therapy.

Periodontitis predicts HbA1c levels and glucose variability in type 1 diabetic patients: the PARODIA Florence Project study

M. Caliri, I. Dicembrini, E. Mannucci, 2022, Clinical Oral Investigations.

Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials

M. Monami, I. Dicembrini, E. Mannucci, 2019, Journal of Endocrinological Investigation.

Sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors and cancer: A meta‐analysis of randomized controlled trials

M. Monami, I. Dicembrini, B. Nreu, 2019, Diabetes, obesity & metabolism.

Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)

M. Monami, I. Dicembrini, E. Mannucci, 2022, Acta Diabetologica.

Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?

P. Pozzilli, I. Dicembrini, E. Mannucci, 2013, Diabetes Care.

Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review

M. Caliri, M. Monami, I. Dicembrini, 2020, Acta Diabetologica.

Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis

M. Porta, M. Monami, I. Dicembrini, 2014, Journal of Endocrinological Investigation.

Lixisenatide: clinical profile and available evidence

I. Dicembrini, E. Mannucci, M. Bigiarini, 2014 .

Cardiovascular effects of basal insulins

I. Dicembrini, E. Mannucci, S. Giannini, 2015, Drug, healthcare and patient safety.

Clinical trials comparing basal insulins Glargine versus NPH

I. Dicembrini, E. Mannucci, S. Giannini, 2015 .

Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study

M. Monami, I. Dicembrini, E. Mannucci, 2011, Journal of nutrition and metabolism.

The selective interaction of lixisenatide leads to an increase in intracellular cAMP and stimulates glucose‑dependent insulin secretion from pancreatic b‑cells, simultaneously decreasing glucagon secretion from a‑cells. Lixisenatide slows gastric emptying, thus improving postprandial glucose control

I. Dicembrini, E. Mannucci, M. Bigiarini, 2014 .

Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials

M. Monami, I. Dicembrini, E. Mannucci, 2020, Acta Diabetologica.

Endocrine System and Cardiovascular Disease

I. Dicembrini, C. Rotella, L. Pala, 2017 .

Lipids seasonal variability in type 2 diabetes.

I. Dicembrini, C. Rotella, S. Giannini, 2012, Metabolism: clinical and experimental.

Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials

I. Dicembrini, E. Mannucci, L. Pala, 2019, Acta Diabetologica.

Fournier's gangrene and sodium‐glucose co‐transporter‐2 inhibitors: A meta‐analysis of randomized controlled trials

M. Monami, I. Dicembrini, E. Mannucci, 2020, Diabetes, obesity & metabolism.

Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials.

M. Monami, I. Dicembrini, B. Nreu, 2020, Minerva endocrinologica.

Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials

M. Monami, I. Dicembrini, E. Mannucci, 2014, Acta Diabetologica.

Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials

G. Sesti, F. Andreozzi, M. Monami, 2017, Acta Diabetologica.

Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

D. Balzi, N. Marchionni, M. Monami, 2010, Diabetes Care.

Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials

M. Monami, I. Dicembrini, B. Nreu, 2020, Endocrine.

Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials

M. Monami, I. Dicembrini, B. Nreu, 2019, Diabetes, obesity & metabolism.

Impact of technology on glycaemic control in type 2 diabetes: A meta‐analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion

M. Monami, I. Dicembrini, E. Mannucci, 2019, Diabetes, obesity & metabolism.

From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy

I. Dicembrini, C. Rotella, L. Pala, 2011, Experimental diabetes research.

Is there a practical way of predicting therapeutic success in type 2 diabetes on the basis of psychological features? Development and validation of the Psychological Predictors of Therapeutic success in Diabetes (PPTD) questionnaire

V. Ricca, I. Dicembrini, E. Mannucci, 2014, Acta Diabetologica.

Fasting and post-prandial glucose and diabetic complication. A meta-analysis.

J. E. Adalsteinsson, M. Monami, I. Dicembrini, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies

S. Tafuri, I. Dicembrini, E. Mannucci, 2023, Acta Diabetologica.

Effects of home confinement during COVID-19 outbreak on glycemic control in patients with type 2 diabetes receiving telemedicine support

I. Dicembrini, E. Mannucci, G. Giove, 2021, Acta Diabetologica.

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes

C. Faravelli, I. Dicembrini, E. Mannucci, 2013, TheScientificWorldJournal.

The therapy of insulin resistance in other diseases besides type 2 diabetes

I. Dicembrini, C. Rotella, L. Pala, 2014, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.

A meta‐analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes

M. Monami, I. Dicembrini, B. Nreu, 2014, Diabetes, obesity & metabolism.

Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study—The “PAROdontopatia e DIAbete” (PARODIA) project

M. Caliri, I. Dicembrini, E. Mannucci, 2021, Acta Diabetologica.

Fournier's gangrene and sodium‐glucose co‐transporter‐2 inhibitors: A meta‐analysis of randomized controlled trials

M. Monami, I. Dicembrini, E. Mannucci, 2019, Diabetes, Obesity and Metabolism.

Dipeptidyl peptidase‐4 inhibitors and pancreatitis risk: a meta‐analysis of randomized clinical trials

M. Monami, I. Dicembrini, E. Mannucci, 2014, Diabetes, obesity & metabolism.

Orlistat and sibutramine beyond weight loss.

I. Dicembrini, E. Mannucci, C. Rotella, 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

N. Marchionni, A. Ungar, P. Bagnoli, 2013, Current medical research and opinion.

Predictors of efficacy of Sodium‐GLucose Transporter‐2 inhibitors and Glucagon‐Like Peptide 1 receptor agonists: A retrospective cohort study

I. Dicembrini, E. Mannucci, Daniele Scoccimarro, 2023, Diabetes/metabolism research and reviews.